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A large body of evidence suggests that women are often more prosocial (for example, generous, altruistic and inequality averse) than men, at least when other factors such as reputa-
tion and strategic considerations are excluded1–3. This dissociation 
could result from cultural expectations and gender stereotypes, 
because in Western societies women are more strongly expected 
to be prosocial4–6 and sensitive to variations in social context than 
men1. It remains an open question, however, whether and how on 
a neurobiological level the social preferences of women and men 
arise from differences in brain functioning. The assumption of gen-
der differences in social preferences predicts that the neural reward 
system’s sensitivity to prosocial and selfish rewards should differ 
between women and men. Specifically, the hypothesis would be that 
the neural reward system is more sensitive to prosocial than self-
ish rewards in women and more sensitive to selfish than prosocial 
rewards in men. The goal of the current study was to test in two 
independent experiments for the hypothesized gender differences 
on both a pharmacological and a haemodynamic level. In particu-
lar, we examined the functions of the neurotransmitter dopamine 
using a dopamine receptor antagonist, and the role of the striatum 
(a brain region strongly innervated by dopamine neurons) during 
social decision-making in women and men using neuroimaging.
The neurotransmitter dopamine is thought to play a key role in 
neural reward processing7,8. Recent evidence suggests that dopa-
minergic activity is sensitive not only to rewards for oneself but to 
rewards for others as well9. The assumption that dopamine is sensi-
tive to both self- and other-related outcomes is consistent with the 
finding that the striatum shows activation for both selfish and shared 
rewards10–15. The dopaminergic response may represent a net signal 
encoding the difference between the value of preferred and unpre-
ferred rewards8. Regarding the hypothesized gender differences in 
social preferences, this account makes the following predictions. If 
women prefer shared (prosocial) outcomes2, women’s dopaminergic 
signals to shared rewards will be stronger than to non-shared (self-
ish) rewards, so reducing dopaminergic activity should bias women 
to make more selfish decisions. In line with this hypothesis, a func-
tional imaging study reported enhanced striatal activation in female 
participants during charitable donations11. In contrast, if men pre-
fer selfish over prosocial rewards, dopaminergic activity should be 
enhanced to selfish compared to prosocial rewards. In line with 
this view, upregulating dopaminergic activity in a sample of exclu-
sively male participants increased selfish behaviour in a bargaining 
game16. Thus, contrary to the hypothesized effect in women, reduc-
ing dopaminergic neurotransmission should render men more pro-
social. Taken together, the current study tested the following three 
predictions: we expected the dopaminergic reward system (1) to be 
more sensitive to prosocial than selfish rewards in women and (2) 
to be more sensitive to selfish than prosocial rewards in men. As a 
consequence of these two predictions, we also predicted (3) dopa-
minoceptive regions such as the striatum to show stronger activa-
tion to prosocial relative to selfish rewards in women than in men.
To test these predictions, we conducted a pharmacological study 
in which we reduced dopaminergic neurotransmission with amisul-
pride. Amisulpride is a dopamine antagonist that is highly specific 
for dopaminergic D2/D3 receptors17. After receiving amisulpride or 
placebo, participants performed an interpersonal decision task18–20, 
in which they made choices between a monetary reward only for 
themselves (selfish reward option) and sharing money with others 
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(prosocial reward option). We expected that blocking dopaminer-
gic neurotransmission with amisulpride, relative to placebo, would 
result in fewer prosocial choices in women and more prosocial 
choices in men. To investigate whether potential gender-related 
effects of dopamine are selective for social decision-making, we also 
tested the effects of amisulpride on time preferences in a non-social 
control task that was matched to the interpersonal decision task in 
terms of choice structure.
In addition, because dopaminergic neurotransmission plays a 
crucial role in brain regions involved in value processing, such as 
the striatum21, a gender-related role of dopaminergic activity for 
social decision-making should also be reflected by dissociable activ-
ity patterns in the striatum. Therefore, to further test our hypoth-
esis, we investigated the neural correlates of social decision-making 
in a functional imaging study. In line with our predictions for the 
pharmacological study, we expected to find stronger striatum activ-
ity during prosocial relative to selfish decisions in women, whereas 
men should show enhanced activity in the striatum for selfish rela-
tive to prosocial choices.
Results
We conducted a randomized, double-blind, placebo-controlled, 
crossover study. In two consecutive sessions, female and male par-
ticipants either received the selective D2/D3 antagonist amisulpride 
in session 1 and placebo in session 2, or vice versa (Fig. 1a). In both 
sessions, participants performed an interpersonal decision task and 
a non-social intertemporal control task (in counterbalanced order). 
In the interpersonal decision task (Fig. 1b), participants made choices 
between a selfish reward only for themselves (7.5–15.5 Swiss francs 
(CHF)) and a prosocial reward that was equally shared between 
themselves and a person at varying social distances (CHF7.5 both 
for the participant and for other). The social distance of the other 
person ranged from very close to being a stranger. In the intertem-
poral decision task (Fig.  1c), participants chose between smaller-
sooner (SS) rewards (for example, CHF80 today) and larger-later 
(LL) rewards (for example, CHF100 in 90 days). Both the interper-
sonal and intertemporal decision task measure how the subjective 
value of a reward option is discounted as a function of (social or 
temporal) distance. These tasks thus allowed a comparison of the 
gender-specific effects of the pharmacological intervention on social 
relative to individual decision-making, while keeping the choice 
structure of the used tasks constant.
Female and male participants were matched for baseline mea-
sures that might potentially influence drug effects on the dopami-
nergic system, including age (t < 1, P = 0.32, Cohen’s d = 0.24), body 
mass index (BMI) (t < 1.42, P = 0.16, Cohen’s d = 0.39) and work-
ing memory capacity (digit span forward: t < 1, P = 0.93, Cohen’s 
d = 0.03; digit span backward: t < 1.21, P = 0.23, Cohen’s d = 0.33). In 
addition, there was no evidence that amisulpride changed partici-
pants’ self-reported mood, alertness or calmness during the experi-
ment (all F < 1.75, all P > 0.19, all partial eta squared, ηp2 < 0.040). 
This suggests that potential drug effects on task performance can-
not be attributed to drug-related mood changes.
Reducing dopaminergic activity differentially modulates social 
preferences in men and women. In the interpersonal decision task 
under placebo, female subjects chose the prosocial reward option 
more often than male subjects (t(53) = 2.01, P = 0.049, Cohen’s 
d = 0.55), which is consistent with the findings that women have 
stronger preferences for shared outcomes than men2,22. To test the 
role of dopaminergic neurotransmission in prosocial and selfish 
decision-making, we examined the effects of amisulpride on choices 
between sharing and non-sharing in female and male participants. 
We computed a mixed-measures analysis of variance (ANOVA) 
on prosocial decisions (% sharing of all decisions) including the 
within-participant factor Substance (amisulpride versus placebo) 
and the between-participant factors Gender (female versus male) 
and Substance Order (amisulpride–placebo versus placebo– 
amisulpride). Only the Substance × Gender interaction yielded a 
significant effect (F(1,51) = 10.92, P = 0.002, ηp2 = 0.176), indicating 
dissociable effects of dopamine on social decision-making in female 
and male participants (all other effects F < 2.2, all P > 0.14, all 
ηp2 < 0.019). Planned comparisons revealed that females made fewer 
prosocial choices under amisulpride (45%) than under placebo 
(51%) (t(26) = 2.64, P = 0.014, Cohen’s d = 0.52). In contrast, males 
made more prosocial choices in the amisulpride (44%) than in the 
placebo condition (40%) (t(27) = 2.29, P = 0.030, Cohen’s d = 0.43). 
Note that this result pattern is at variance with the possibility that 
choices have become more random under amisulpride because 
females’ choices were closer to the 50% level under placebo than 
under amisulpride. Importantly, the data confirm the hypothesized 
gender-related role of dopamine in social decision-making (Fig. 2a 
and Supplementary Fig. 1a,b).
Because females were more prosocial than males in the pla-
cebo condition, one might wonder whether the drug effects on 
social decision-making depend on individual differences in base-
line prosociality rather than on gender. To control for this poten-
tial confounder, we entered the number of prosocial decisions 
under placebo as a covariate in the above reported ANOVA. This 
analysis also yielded a significant Substance × Gender interaction 
(F(1,50) = 8.55, P = 0.005, ηp2 = 0.146), but provided no evidence for 
an impact of baseline prosociality on drug effects (F(1,50) = 1.72, 
























Fig. 1 | Study design and experimental tasks. a, Participants performed 
both the interpersonal and intertemporal decision tasks in two sessions. In 
session 1, participants received either the dopamine antagonist amisulpride 
or placebo, and in session 2 (14 days after session 1) the respective other 
substance. b, In the interpersonal decision task, participants made choices 
between a prosocial reward option (CHF7.5 for the participant and for 
the person at the indicated social distance) and a selfish reward option 
(only the participant receives money, for example, CHF11.5). c, In the 
intertemporal decision task, participants chose between a smaller-sooner 
(for example, CHF100 today) and a larger-later (for example, CHF300 in 
90 days) reward option.
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interaction between Substance and Gender also remained signifi-
cant when controlling for individual differences in BMI as a proxy 
for the concentration of amisulpride in the blood (F(1,50) = 9.78, 
P = 0.004, ηp2 = 0.157). These findings suggest that the gender-
related drug effects indeed reflect gender-related functioning of 
the dopaminergic reward systems in social decision-making rather 
than potentially confounding factors such as baseline prosociality 
or effective concentration of amisulpride in the blood.
Next, we tested whether dopamine blockade modulates social 
preferences in general, or whether the effects of amisulpride depend 
on the social distance of the other person. To assess whether the 
drug effects on prosociality are dependent on the social distance 
of the other person, we added the factor Social Distance to our 
ANOVA model. The significant main effect of Social Distance indi-
cated that participants shared money more often with close rather 
than distant others (F(5,255) = 67.20, P < 0.001, ηp2 = 0.569), con-
sistent with previous findings18–20. Importantly, we again observed 
a significant Substance × Gender interaction (F(1,51) = 6.24, 
P = 0.016, ηp2 = 0.109). In addition, this interaction was qualified 
by a three-way Social Distance × Substance × Gender interaction 
(F(5, 255) = 2.34, P = 0.042, ηp2 = 0.044) (Fig. 2b). Females decided to 
share money less often under amisulpride than under placebo with 
close others at social distances 1, 5 and 10 (all t > 2.09, all P < 0.047, 
all Cohen’s d > 0.40), but not with more distant others (all t < 1, all 
P > 0.58, all Cohen’s d < 0.11). An analogous pattern was observed 
in the male sample: relative to placebo, amisulpride rendered males 
more prosocial towards close others, social distances 1 (t(27) = 1.92, 
P = 0.07, Cohen’s d = 0.36) and 5 (t(27) = 2.04, P = 0.05, Cohen’s 
d = 0.39), but not towards more distant others (all t < 1.30, all 
P > 0.20, all Cohen’s d < 0.25). These data suggest that amisulpride 
modulates social preferences predominantly when confronted with 
close others. Again, this pattern of findings speaks against the pos-
sibility that choices became noisier under amisulpride, because ami-
sulpride differentially affected decisions at low social distances even 
though both genders more often chose the prosocial than the selfish 
option under placebo. In both women and men, prosocial choices 
under placebo were significantly above 50% at social distance 1 
(both t > 2.2, both P < 0.04), as well as significantly below 50% at 
social distances 50 and 100 (all t > 5.5, all P < 0.001). If choices had 
become noisier (and thus less determined by an individual’s social 
preferences), both women and men should have shown less proso-
cial choices at social distance 1 under amisulpride compared with 
placebo and more prosocial at social distances 50 and 100 (that is, 
choices should have been closer to the 50% chance level). However, 
neither of these predictions was confirmed by the data, because 
choices at these conditions remained significantly different from 
chance level under amisulpride (all t > 3.8, all P < 0.001), and men 
made even more prosocial choices under amisulpride than under 
placebo at social distance 1. Thus, we can rule out the possibility 
that amisulpride made choices more random instead of modulating 
social preferences.
As a further test of how the effect of dopamine blockade depends 
on social distance, we determined the degree of social discount-
ing for each individual participant by fitting a hyperbolic discount 
function to the individual indifference values in the interpersonal 
decision task (see Methods). The intercept V measures generos-
ity to socially close others, and the discount factor s measures 
the steepness of the discounting of shared rewards with increas-
ing social distance. We analysed the parameter estimates (that 
is, the individually estimated parameters V and s) as the depen-
dent variable in a mixed-measures ANOVA including the factors 
Substance (amisulpride versus placebo), Parameter (V versus s), 
Gender (female versus male), and Substance Order (amisulpride–
placebo versus placebo–amisulpride). The inclusion of the factor 
‘Parameter’ allowed us to test whether the drug effects were stron-
ger on intercept V than on discount factor s. We found significant 
effects of Parameter (F(1,51) = 1,341.33, P < 0.001, ηp2 = 0.963) and 
Substance × Gender (F(1,51) = 8.92, P = 0.001, ηp2 = 0.149), which 
were specified by a three-way Parameter × Substance × Gender 
interaction (F(1,51) = 8.88, P = 0.001, ηp2 = 0.148) (these effects 
are robust to mean-centering the parameter estimates for V and s 
and therefore are not due to scaling differences between V and s). 
These results suggest that amisulpride affected parameters V and s 
differently in the two genders (Fig. 3 and Supplementary Figure 2). 
More specifically, we found that under amisulpride, relative to pla-
cebo, intercept V was significantly reduced in female participants 
(t(26) = 2.07, P = 0.024, Cohen’s d = 0.40) and significantly increased 
in male participants (t(27) = 2.13, P = 0.022, Cohen’s d = 0.40), while 
there were no drug effects on discount factor s in either gender (both 
t < 1, both P > 0.50, both Cohen’s d < 0.13). These findings specify 
the above-reported gender-related drug effects on prosocial choices 
and suggest that, compared to placebo, under amisulpride female 
and male participants tend to be more selfish and prosocial, respec-
tively, when they make sharing decisions about socially close others.
No evidence for gender-related drug effects on non-social 
decision-making. To determine whether the observed gender-
















































Fig. 2 | Gender-related effects of amisulpride on prosocial choices.  
a, Percentage of prosocial choices in the interpersonal decision task (n =  55), 
plotted as a function of gender (female versus male) and substance 
(amisulpride versus placebo). The asterisk indicates significant differences 
(P <  0.05; paired-samples t-tests). Error bars indicate within-subject error 
of the mean difference between amisulpride and placebo, for females 
and males separately. b, Prosocial choices plotted as a function of gender, 
substance and social distance. In both females and males, amisulpride 
affected social preferences predominantly when making decisions about 
socially close others. Error bars indicate standard error of the mean.
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analysed the impact of amisulpride on choices in the intertempo-
ral decision task. Because previous studies related dopaminergic 
activity to preference for SS over LL rewards23,24, we expected 
blocking of dopaminergic activity to lead to a higher number 
of LL choices. More importantly, we expected to find no gender-
related effects of amisulpride on intertemporal choices. In analogy 
to the interpersonal decision task, we analysed the percentage of 
LL choices with a mixed-measures ANOVA including the factors 
Substance (amisulpride versus placebo), Gender (female versus 
male) and Substance Order (amisulpride–placebo versus placebo–
amisulpride). Besides an interaction between Gender and Substance 
Order (which may represent a chance finding; F(1,51) = 6.09, 
P = 0.017, ηp2 = 0.107), no effect passed the statistical threshold (all 
F < 1.20, all P > 0.28, all ηp2 < 0.015), providing no evidence for drug 
effects on intertemporal choices (Fig. 4a). However, when entering 
BMI values (as an approximation for the effective dose of amisul-
pride) as covariate into the analysis, we found a significant main 
effect of Substance (F(1,50) = 4.55, P = 0.038, ηp2 = 0.083), which 
was modulated by a Substance × BMI interaction (F(1,50) = 5.05, 
P = 0.029, ηp2 = 0.092): the lower the BMI (and thus the higher 
the concentration of the drug in the body), the stronger the par-
ticipants’ preference for LL rewards under amisulpride than under 
placebo (Fig.  4b). Importantly, however, the effect of amisulpride 
did not differ between female and male participants, even when 
controlling for BMI, because no further comparison was signifi-
cant (all F < 1.47, all P > 0.23, all ηp2 < 0.028). Thus, as predicted, we 
found no evidence to suggest gender-related effects of amisulpride 
on intertemporal decision-making.
To interrogate the hypothesis-conforming non-significant 
Substance × Gender interaction in more detail, we compared the 
likelihoods of the data under the null hypothesis (drug effects 
are independent of gender) and under the alternative hypothesis 
(gender modulates drug effects) by estimating a Bayes factor using 
the Bayesian information criterion25,26. The estimated Bayes factor 
suggested that it is 7.40 times more likely to observe the data under 
the null hypothesis than under the alternative hypothesis, which, 
according to the guidelines for interpreting Bayes factors27, provides 
substantial support for the null hypothesis of gender-unrelated drug 
effects on intertemporal choices.
To test the task-specificity of the gender effect more strin-
gently, we directly compared drug effects on intertemporal and 
interpersonal choices by running a between-task ANOVA includ-
ing the factors Task (interpersonal versus intertemporal decision 
task), Substance, Gender, and Substance Order. We also included a 
between-subject factor for Task Order to test whether drug effects 
on the decision tasks depended on the order in which participants 
performed the interpersonal and intertemporal decision tasks. The 
ANOVA revealed a significant Task × Substance × Gender interac-
tion (F(1,47) = 8.32, P = 0.006, ηp2 = 0.113), in line with a task-spe-
cific gender-related effect of amisulpride. This three-way interaction 
was independent of potential task order effects (F < 1, P = 0.38, all 
ηp2 = 0.016). These results confirm the findings reported above and 
suggest that amisulpride showed gender-related effects only in the 
interpersonal, but not the intertemporal, decision task.
Striatal activation during social decision-making differs between 
women and men. The results of the pharmacological study suggest 
dissociable roles of dopaminergic neurotransmission for social deci-
sion-making in women and men. Because dopamine plays a cen-
tral role in value-processing brain regions such as the striatum8,21, 
and dopamine manipulations affect haemodynamic value signals 
in the striatum28–30, our findings predict gender-related striatal acti-














































Fig. 3 | Gender-related effects of amisulpride on social discounting 
parameters. a,b, Parameter estimates for undiscounted reward value V 
(a) and discount factor s in the interpersonal decision task (b) (n =  55), 
plotted as a function of gender (female versus male) and substance 
(amisulpride versus placebo). The asterisk indicates significant differences 
(P <  0.05; paired-samples t-tests). Error bars indicate within-subject error 













































Fig. 4 | effects of amisulpride on intertemporal choices. a, In the 
intertemporal decision task (n =  55), there were no gender-related drug 
effects in choices of the larger-later reward. b, Drug effects varied as a 
function of individual BMI, with low-BMI individuals, who probably had 
a higher concentration of amisulpride in their blood, being more patient 
under amisulpride than under placebo (Substance ×  BMI interaction, 
F(1,50) =  5.05, P =  0.029). Error bars indicate within-subject error of the 
mean difference between amisulpride and placebo, for females and  
males separately.
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more pronounced for prosocial behaviour in women and for self-
ish behaviour in men, we expect activation in the striatum related 
to prosocial versus selfish decisions to be stronger in women than 
men. To test this prediction, we combined data from a previous, 
hitherto unpublished, functional magnetic resonance imaging 
(fMRI) experiment (8 female and 9 male participants) and from an 
already published study (11 female and 12 male participants)19. In 
both studies, participants performed the previously described inter-
personal decision task in the MRI scanner. Specifically, we examined 
whether the striatum showed higher activity for prosocial versus 
selfish choices in women relative to men, using a mask for value-
processing regions in the striatum based on recent meta-analyses31,32 
(Fig. 5a). The striatum showed gender-related response differences. 
In agreement with our hypothesis, striatal activations for prosocial 
versus selfish decisions were stronger in female participants than in 
male participants (t(38) = 2.25, P = 0.03, Cohen’s d = 0.73; Fig. 5b). 
An exploratory whole-brain analysis provided no evidence for 
gender differences in any further brain region when using family-
wise error (FWE) correction at the cluster level. At more liberal 
thresholds (P < 0.001, number of voxels, k > 5), females, relative to 
males, showed enhanced activation during prosocial versus selfish 
decisions in the posterior insula (peak coordinates: x = 36, y = − 19, 
z = 13; k = 27 voxels), superior temporal lobe (x = 60, y = − 10, z = 4; 
k = 6 voxels) and the temporoparietal junction (x = 51, y = − 28, 
z = 31; k = 22 voxels).
In the unpublished (but not in the published) experiment, par-
ticipants also performed the intertemporal decision task in the 
scanner. Similar to the pharmacological experiment, this allowed 
us to test whether the gender differences in the interpersonal deci-
sion task are specific for social decision-making. In line with previ-
ous reports33, the striatum was more active for SS than LL choices 
across both genders (t(16) = 2.57, P = 0.021, Cohen’s d = 0.62; 
Fig.  5c). More importantly, striatum activation related to SS ver-
sus LL choices did not differ between female and male participants 
(t(15) = 1.26, P = 0.22, Cohen’s d = 0.61; Fig.  5c). Also, an explor-
atory whole-brain analysis provided no evidence for neural gender 
differences during intertemporal choice even at more liberal thresh-
olds (P < 0.001, k > 5). In contrast, in the interpersonal decision 
task, the gender difference was significant even when restricting the 
analysis to the sample of the unpublished experiment (t(15) = 2.24, 
P = 0.048, Cohen’s d = 1.16). This gender difference in striatal 
activation was also independent of different payoff structures 
of the prosocial reward (see Methods and Supplementary Fig. 3). 
Thus, despite the small sample size of the unpublished experiment, 
which should be kept in mind as a caveat, we found significant 
gender differences  that were selective for interpersonal choice. 
Together, the neuroimaging results mirror the results from the 
pharmacological experiment and suggest dissociable roles of the 
neural reward system in women and men for social, but not indi-
vidual, decision-making.
Discussion
The current study provides a neurobiological foundation for a well-
documented gender difference in sharing behaviour1,2. We find that 
in females the dopaminergic reward system is more sensitive to 
shared than to selfish rewards, while the opposite is true for males. 
This conclusion is evidenced both by the pharmacological and neu-
roimaging data.
Pharmacologically blocking dopaminergic transmission reduced 
prosociality in women and selfishness in men. This finding is com-
patible with the notion that dopamine encodes value and promotes 
reward seeking7,8,34. According to a recent theoretical account on 
gender differences in social preferences2, sharing tends to be more 
preferable than acting selfishly for women, whereas, for men, maxi-
mizing self-reward tends to carry more value. It is important to note 
that dopaminergic signals may encode the subjective value of both 
prosocial and selfish reward options in both genders, rather than 
encoding selectively the value of the prosocial reward option in 
women and the value of the selfish reward option in men. However, 
due to the different biases of women and men for prosocial and self-
ish rewards, respectively, dopaminergic signals may more strongly 
encode shared (relative to selfish) rewards in women and selfish 
(relative to shared) rewards in men. Dopamine receptor blockade 
would then reduce the impact of these aspects on the decision pro-
cess, in line with our finding of increased selfish choices in women 
and prosocial choices in men.
The gender-related effects of dopamine receptor blockade are 
mirrored by the finding that, compared to males, females show 
enhanced striatal activations during prosocial relative to selfish 
decisions. Our results are consistent with previous single-gender 
findings of enhanced striatal activation during costly sharing in 












































































Fig. 5 | Results of the neuroimaging study. a, Pre-defined mask of value-processing regions in the striatum (which served as a region of interest 
for examining decision-related activity during interpersonal and intertemporal decision tasks. b, In the interpersonal decision task (n =  40), female 
participants showed stronger striatum activation related to choices of prosocial versus selfish rewards than male participants (t(38) =  2.25, P =  0.03), 
consistent with the findings of the pharmacological experiment. c, In contrast, in the intertemporal decision task (n =  17), striatum activation related 
to choices of SS versus LL rewards did not differ between female and male participants (t(15) =  1.26, P =  0.22). Because the number of female or male 
participants was relatively low for this comparison, we display individual data points. The asterisk indicates significant difference (P <  0.05; independent-
samples t-tests). Error bars indicate standard error of the mean.
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neurotransmission in men16. The present findings inform and qual-
ify these previous studies by showing the necessity of considering 
gender differences in the neuroscience of social decision-making 
and provide a link between dopamine and gender differences in 
prosocial preferences. Our results are also consistent with the view 
that gender differences in the brain are functional, rather than mor-
phological, in nature35,36.
In contrast to the clear gender-related effects observed in inter-
personal decision-making, neither the pharmacological nor the 
imaging study revealed evidence for gender-differences in the para-
digm we used to assess intertemporal decision-making. Although 
there is some evidence that temporal discounting may differ 
between women and men37, our findings suggest that these poten-
tial differences appear to be smaller than in isomorphic social dis-
counting tasks and unrelated to dopaminergic functioning.
It is worth keeping in mind that the currently observed gender 
differences do not have to be innate or hard-wired. In contrast, 
because dopaminergic activity plays a role in reward learning and 
encodes the learned value of actions or stimuli8,29, gender-related 
reward processing may be the result of education and/or cultural 
expectations4,5. Note that we do not assume such cultural expecta-
tions or stereotypes to describe gender differences that exist inde-
pendently of these stereotypes. Instead, these stereotypes might 
function as self-fulfilling prophecies and produce the gender dif-
ferences they claim to describe. For example, from an early age, 
women may receive more positive feedback for prosocial behav-
iour than men, which may lead to an internalization of cultural 
norms and make prosocial behaviour more valuable and predic-
tive of rewarding feedback4. If true, this notion would suggest that 
the presently observed effects are not an expression of hard-wired 
differences between men and women per se, but rather that educa-
tion and learning history may be the driving factors for differential 
associations of high reward value to different behaviours by the 
dopaminergic reward system. Consistent with the assumption of 
cultural influences on dopaminergic functioning, polymorphisms 
of dopaminergic receptor genes appear to be associated with 
more independent social orientation in European Americans and 
more interdependent social orientation in Asians38. Together, 
experience may shape the sensitivity of the dopamine system to 
social information.
The observed effects cannot be explained by findings showing 
that the same dose of amisulpride leads to higher plasma concentra-
tions in the blood of females than of males39, or that males have a 
higher striatal D2 receptor density than females40. This is because 
the gender differences were specific to social decision-making, 
while non-social tasks showed no gender-related drug effects. It is 
also worth noting that there were no gender differences in work-
ing memory capacity (as a proxy for baseline dopamine levels), so 
the observed effects cannot be explained by an inverted-U effect 
of dopamine on cognition (which would, moreover, not have been 
limited to the domain of social decision-making). Thus, due to the 
high task-specificity of our findings, a gender-related role of dopa-
mine in prosocial decision making, rather than gender differences 
in amisulpride absorption per se, offers the most parsimonious 
explanation for our findings.
Although the actions of amisulpride on D2/D3 receptors are rela-
tively selective, it also blocks serotonergic 5-HT7-receptors41. Some 
evidence in humans suggests that the dopamine and serotonin sys-
tems play opposing or at least complementary roles23,24,42–44. In this 
view, the serotonin system primarily underpins punishment pro-
cessing, whereas the dopamine system primarily underpins reward 
processing. However, the specific function of the 5-HT7-receptor in 
cognitive processes remains largely unknown, except for a role in 
memory formation, sleep and psychiatric disorders45. Activation of 
5-HT7 receptors in rat ventral striatum decreased ambulatory activ-
ity but had no effects on reward-related behaviour46. On balance, we 
therefore believe that it is unlikely that the present effects of amisul-
pride were mediated by 5-HT7 actions.
To conclude, we have advanced the current understanding of the 
neurobiological roots of costly giving. By providing evidence for a 
dissociable role of dopamine in social decision-making for men and 
women, our data corroborate a recent theoretical account assum-
ing crucial gender differences in social decision-making and offer 
a biological account of the finding that prosocial behaviour is often 
more widespread in women than in men.
methods
Pharmacological study (Study 1). Participants. A total of 56 participants  
(27 female, Mage = 23.2 years, SDage = 3.1 years) were recruited at the University of 
Zurich to participate in the study. The study protocol was approved by the Research 
Ethics Committee of the canton of Zurich. All participants gave written informed 
consent. One male participant was excluded from analysis due to not following task 
instructions (he did not indicate any persons for the social distance levels 1–20). 
For their participation, participants were paid CHF30 per hour and a monetary 
bonus depending on their choices (see 'Experimental design and procedure').
Interpersonal decision task. Participants performed an interpersonal decision 
task in which they had to choose between a selfish reward option (CHF7.5–15.5) 
and a prosocial reward option (CHF7.5 for both the participant and a second 
person)18–20. The social distance of the other person ranged from very close others 
to complete strangers. In more detail, at the start of the experiment (before drug 
intake), we asked participants to imagine a list of 100 people ranging from 1 
(the person socially closest to them) to 100 (a random stranger on the street). 
A person at rank 50 was described as a person the participants had seen several 
times without knowing the name of the person. We discouraged participants to 
think of people they felt negatively towards. In the computer experiment, we used 
the social distances of 1, 5, 10, 20, 50 and 100. For each trial of the interpersonal 
decision task, the amount of the selfish reward option (for example, ‘CHF 12.5 
self only’) and the social distance of the other (for example, ‘Person 20’) were 
displayed (Fig. 1b), with one option presented above a central fixation cross and 
the other below the fixation cross (counterbalanced across participants). Note that 
the amount of the prosocial reward option was not displayed because it was fixed 
at CHF7.5 for both. Participants were instructed to press the left or right control 
key on a QWERTZ keyboard to choose the selfish or prosocial reward option (the 
assignment of keys to choice options was counterbalanced across participants).
In each trial, the choice options were displayed until participants responded. 
The next trial started after an inter-trial interval (ITI) of 1 s. Each combination of 
social distance and selfish reward level was presented once during the experiment, 
resulting in a total of 54 trials for the interpersonal decision task. Trials were 
presented in randomized order.
Intertemporal decision task. To test whether gender-related effects of amisulpride 
on the interpersonal decision task are selective for social decisions, participants 
also performed an intertemporal decision task as a non-social control task33. 
We decided to use an intertemporal decision task as the control task because, in 
the literature, the role of dopamine in time preferences has already been well-
described23,24,42. In this task, participants made choices between SS (for example, 
CHF80 today) and LL reward options (for example, CHF100 in 90 days). We used a 
dynamic version of this task in which the choice options were individually selected 
so that the information provided by each decision was optimized (dynamic 
experiments for estimating preferences, DEEP47). Choice options were presented 
on the left or right screen side, and the screen sides for the SS and LL reward 
option were counterbalanced across trials. Participants pressed the left or right 
arrow keys on a QWERTZ keyboard to choose the option presented on the left or 
right screen side.
On each trial, the reward options were presented until participants made a 
choice (Fig. 1c). The next choice options were displayed after an ITI, during which 
a central fixation cross was presented for 1 s. Participants made a total of 20 choices 
between SS and LL reward options.
Experimental design and procedure. All participants completed two experimental 
sessions (each taking 4 h), which were separated by exactly 14 days. The 
experiment followed a randomized, double-blind, placebo-controlled crossover 
design: half of the participants received an oral dose of 400 mg amisulpride (Solian) 
in the first session and placebo (mannitol) in the second session, and vice versa 
for the other half of the participants (Fig. 1a). Participants were not aware of 
whether they received placebo or amisulpride, as assessed by a post-experimental 
questionnaire (χ2(1) < 1, P = 0.76), in line with previous, independent studies 
using the same dose of amisulpride23,48. Before substance intake, participants 
performed the digit span task forwards and backwards to measure working 
memory performance as a proxy of baseline dopamine synthesis capacity49,50. 
Moreover, participants performed a mood questionnaire before substance intake 
and at the end of the experiment to control for potential drug effects on mood. 
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The experimental tasks were performed ~1.5 h after substance intake, that is, 
0.5 h after the first peak in amisulpride plasma level concentration. As well as 
the interpersonal decision task and the intertemporal decision task, participants 
performed further experimental tasks measuring risk and effort preferences, a 
reversal learning task, and a stop-signal task (in counterbalanced order). The 
results for these tasks will be reported in a separate article. Importantly, none of 
these tasks showed gender-related drug effects or gender differences under placebo 
(all F < 2.47, all P > 0.12).
The task was incentive-compatible. Specifically, participants knew beforehand 
that, at the end of the experiment, one single trial would be randomly selected and 
implemented both for the interpersonal decision task and for the intertemporal 
decision task. If participants had chosen the selfish or SS reward option in the 
selected trial, they received the corresponding amount of the selfish reward 
option or SS reward option immediately, and in addition to their basic payment. 
If participants had chosen the prosocial reward option in the interpersonal 
decision task, both they and the person at the corresponding social distance 
received CHF7.5. The contact details of the other person were recorded after 
the experimental session and the money was sent to the other person by mail. 
Similarly, if participants had chosen the LL reward in the intertemporal decision 
task, the corresponding LL amount was sent to the participant after the temporal 
delay of the chosen option. Participants were explicitly instructed that they should 
take all decisions seriously, as every decision had equal probability of being chosen 
at the end and implemented.
Data analysis. Statistical analysis of the behavioural data was performed with 
Matlab R2014b (MathWorks) and IBM SPSS Statistics 22. For the interpersonal 
decision task, we computed hyperbolic discount functions reflecting the 
discounted subjective value of the prosocial reward as a function of social 
distance, following the procedure taken by previous studies18–20. We first calculated 
individual indifference points using logistic regression predicting choice as a 
function of selfish reward level. Each indifference point was defined as the value 
at which a participant would choose the prosocial and the selfish reward option 
with an equal probability of 50%. These indifference points were computed 
separately for each social distance. Finally, social discount functions were fitted 
to the indifference points, separately for each participant. We assumed that social 
discounting can be described by the following standard hyperbolic function18:
= ∕ + ×SV V s D(1 ) (1)
where SV is the discounted value of the prosocial reward option, and V is the 
undiscounted value of the prosocial reward and determines the height of the 
discount function at social distance 0 (intercept). D indicates the social distance 
of the other person, and s represents a participant-specific constant measuring 
the degree of discounting. A larger s corresponds to stronger social discounting, 
that is, a stronger increase in selfish choices with increasing social distance. 
The undiscounted reward value V as well as the discount parameter s were free 
parameters and were determined separately for each participant by fitting equation 
(1) to their indifference points.
We analysed choices as well as the parameter estimates for V and s in the 
interpersonal and intertemporal decision tasks with mixed-measures ANOVAs as 
implemented in SPSS Statistics 22. In addition, we conducted planned comparisons 
to test the hypothesized gender-related effects of amisulpride on social decision-
making. The alpha threshold was set to 5% for all tests.
Neuroimaging study (Study 2). For the neuroimaging study, we collapsed the 
data from two separate functional imaging experiments in which subjects had 
performed the interpersonal decision task in the fMRI scanner. The data of 
the first experiment (neuroimaging experiment 1) were published previously19 
without having analysed gender differences, whereas the data of the second 
experiment (neuroimaging experiment 2) have not yet been published.  
Both studies were conducted before the pharmacological study and did not 
include any pharmacological manipulation. Combining the data sets from these 
two studies allowed us to test for gender-related blood-oxygen-level dependent 
(BOLD) responses in the neural reward system with adequate sample sizes  
(19 women, 21 men).
Neuroimaging experiment 1. Participants. The sample of the first imaging 
experiment comprised 11 female and 12 male participants.
Task design and image acquisition. Participants performed the interpersonal 
decision task in a similar way as in the pharmacological study: participants 
made choices between selfish reward options (ranging from € 75 to € 165) and 
sharing money with other persons at varying social distances. Similar to the 
pharmacological study, the amounts of the prosocial reward option were fixed at  
€ 75 for the subject and the other (for details and a description of image acquisition, 
see ref. 19).
Functional imaging analysis. All imaging analyses were performed with SPM 12 
(www.fil.ion.ucl.ac.uk/spm). We tested whether the striatum shows  
gender-related effects in the general linear model (GLM), which included two 
separate onset regressors of main interest, one for prosocial decisions and one for 
selfish decisions in the interpersonal decision task, modelled at the corresponding 
decision times. The GLM also included onset regressors for the presentation of 
the social distance, the prosocial reward option and the selfish reward option, as 
well as six movement parameters as covariates of no interest. All regressors were 
convolved with the canonical haemodynamic response function. We then extracted 
regression parameters comparing activity related to prosocial versus selfish choices 
in every voxel within a predefined region of interest (ROI; see next section) for 
each participant. Gender differences in the extracted beta values were tested with 
independent-samples t-tests. In addition to the ROI analysis, we performed an 
exploratory whole-brain analysis by estimating regression parameters in every 
voxel for each participant. We then entered the parameter estimates in a between-
participant, random-effects analysis to obtain statistical parametric maps for 
independent-sample t-tests comparing activity related to prosocial versus selfish 
choices. We used family-wise error correction at the cluster level to correct for 
multiple comparisons (P < 0.05, with a cluster-inducing threshold of P < 0.001).
ROI definition. We focused on the striatal regions where activity correlated with 
subjective value, as recently identified in independent meta-analyses31,32. This 
mask is based on the conjunction of all voxels in the striatum showing a significant 
positive correlation with the value of rewards during decision-making in these 
meta-analyses, and can be downloaded from http://www.rnl.caltech.edu/resources/
index.html.
Neuroimaging experiment 2. Participants. Seventeen volunteers (8 female and 
9 male; Mage = 23.7; SDage = 5.6) participated in the study after giving written 
informed consent. The study was approved by the Research Ethics Committee of 
Zurich. Participants received CHF50 and a monetary bonus depending on their 
choices (see next section).
Task design and procedure. Participants performed the interpersonal and 
intertemporal decision tasks in a similar way as in study 1. In the interpersonal 
decision task, the height of the selfish reward option varied from CHF65 to 
CHF155 in steps of 10. For the prosocial reward option, three generosity levels 
were used: CHF75 for self and CHF75 for the other, CHF75 for self and CHF25 
for the other, CHF100 for self and CHF50 for the other. As the current study 
focused on a comparison between choices of the prosocial and the selfish  
reward option, we collapsed data across different generosity levels for the 
following analyses.
Each trial of the interpersonal decision task started with a presentation of the 
social distance information. Then, either the selfish or prosocial reward option was 
presented, followed by the second choice option. The social distance information 
was presented first (2–3 s), followed by the two choice options (also 2–3 s). Next, 
participants had 3 s to indicate their response by pressing a left or right response 
key for the option presented on the left or right screen side, respectively. At the end 
of each trial, a feedback indicating the choice was shown for 0.5 s. The minimum 
ITI was 2 s and was jittered with a Poisson distribution (maximum ITI of 13 s). 
Consequently, the total length of a trial varied from 11.5 to 25.5 s.
In the intertemporal decision task, participants chose between SS and LL 
rewards. The SS reward ranged from CHF30 to CHF150 in steps of 30, which 
resulted in five SS reward levels. The LL reward was held constant at CHF160, with 
the temporal delay varying from 3 to 15 months in steps of 3, which resulted in  
five delays.
For each trial, we first presented either the SS reward option or the LL  
reward option, followed by the corresponding alternative option. As in the 
interpersonal decision task, the choice options were presented for 2–3 s. After 
the presentation of the second option, the decision period started (3 s), in which 
participants had to indicate their response by pressing a left or right response key 
for the option presented on the left or right screen side, respectively. Feedback was 
presented for 0.5 s. The ITI ranged from 2 s to 13 s, resulting in a total trial length 
from 9.5 to 22.5 s.
Participants performed five runs, each including 42 interpersonal decisions and 
20 intertemporal decisions. The task order within each run was randomized across 
participants. As in the pharmacological experiment, one trial in each task was 
randomly selected at the end of the experiment and implemented.
Image acquisition. The fMRI sessions were performed at the Laboratory for Social 
and Neural Systems Research (SNS lab) at the University Hospital of Zurich. The 
MRI system used was a 3 T Philips Achieva whole-body scanner equipped with an 
eight-channel SENSE head coil (Philips Medical Systems). The functional images 
were acquired using a BOLD-T2*-weighted single-shot echo-planar imaging (EPI) 
pulse sequence. The acquisition parameters were determined as follows: TE = 30 ms, 
TR = 1,565 ms, with a flip angle of 75°, field of view (FOV) = 240 × 216 × 119 mm², 
acquisition matrix = 80 × 72, voxel size = 3 × 3 × 3 mm³, with a slice gap of 1 mm. 
The anatomical T1-weighted images were obtained after the decision tasks were 
completed using a turbo field echo (TFE) pulse sequence with a flip angle of 8°. 
The acquisition matrix ranged over 228 × 227 with an FOV of 250 × 250 mm² and a 
voxel size of 1.1 × 1.1 × 0.6 mm³.
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Functional imaging analysis. The functional data of each participant were 
slice-timing-corrected, motion-corrected, unwarped, and co-registered to the 
anatomical image. Following segmentation, we spatially normalized the data 
into standard Montreal Neurological Institute (MNI) space. Finally, data were 
smoothed with an 8 mm full-width at half-maximum (FWHM) Gaussian kernel 
and high-pass-filtered during statistical analysis.
We analysed the data for the interpersonal decision task with a GLM identical 
to that used for the first neuroimaging experiment. This allowed us to collapse the 
data from the current sample with the data from the previous study19. A similar 
GLM was set up to analyse data in the intertemporal decision task. This GLM 
included two onset regressors of main interest, one for choices of the SS reward 
option and one for choices of the LL reward option at decision time. In addition, 
the model included onset regressors for presentation of the SS and LL reward 
options, as well as movement parameters as regressors of no interest. Again, we 
used the predefined mask for the striatum to extract the beta values contrasting 
prosocial versus selfish decisions in the interpersonal decision task and SS versus 
LL reward choices in the intertemporal decision task. Finally, we collapsed the 
data for the interpersonal decision task from imaging experiment 1 and imaging 
experiment 2 and tested for gender differences in the functional striatum mask 
with independent-samples t-tests. Because we combined data from two different 
scanners, we added a dummy-coded covariate (‘0’ for neuroimaging experiment 1 
and ‘1’ for neuroimaging experiment 2) to the GLM for the second-level analysis 
of the interpersonal decision task in order to control for potential effects of the 
different scanners.
Data availability. The data that support the findings of this study are available 
from the corresponding author upon request.
Received: 8 March 2017; Accepted: 12 September 2017;  
Published online: 9 October 2017
References
 1. Croson, R. & Gneezy, U. Gender differences in preferences. J. Econ. Lit. 47, 
448–474 (2009).
 2. Rand, D. G., Brescoll, V. L., Everett, J. A., Capraro, V. & Barcelo, H. Social 
heuristics and social roles: intuition favors altruism for women but not for 
men. J. Exp. Psychol. Gen. 145, 389–396 (2016).
 3. Rand, D. G. Social dilemma cooperation (unlike dictator game giving) is 
intuitive for men as well as women. J. Exp. Soc. Psychol. 73, 164–168 (2017).
 4. Heilman, M. E. & Chen, J. J. Same behavior, different consequences: reactions 
to men’s and women’s altruistic citizenship behavior. J. Appl. Psychol. 90, 
431–441 (2005).
 5. Eagly, A. H. Sex Differences in Social Behavior: A Social-role Interpretation  
(L. Erlbaum Associates, Hillsdale, NJ, 1987).
 6. Eagly, A. H. & Crowley, M. Gender and helping behavior: a meta-analytic 
review of the social psychological literature. Psychol. Bull. 100, 283–308 (1986).
 7. Schultz, W. Multiple dopamine functions at different time courses. Annu. Rev. 
Neurosci. 30, 259–288 (2007).
 8. Schultz, W. Neuronal reward and decision signals: from theories to data. 
Physiol. Rev. 95, 853–951 (2015).
 9. Saez, I., Zhu, L., Set, E., Kayser, A. & Hsu, M. Dopamine modulates 
egalitarian behavior in humans. Curr. Biol. 25, 912–919 (2015).
 10. Tricomi, E., Rangel, A., Camerer, C. F. & O’Doherty, J. P. Neural evidence  
for inequality-averse social preferences. Nature 463, 1089–1091 (2010).
 11. Harbaugh, W. T., Mayr, U. & Burghart, D. R. Neural responses to taxation 
and voluntary giving reveal motives for charitable donations. Science 316, 
1622–1625 (2007).
 12. Mobbs, D. et al. A key role for similarity in vicarious reward. Science 324,  
900 (2009).
 13. Fareri, D. S., Niznikiewicz, M. A., Lee, V. K. & Delgado, M. R. Social network 
modulation of reward-related signals. J. Neurosci. 32, 9045–9052 (2012).
 14. Hsu, M., Anen, C. & Quartz, S. R. The right and the good: distributive justice 
and neural encoding of equity and efficiency. Science 320, 1092–1095 (2008).
 15. Morelli, S. A., Sacchet, M. D. & Zaki, J. Common and distinct neural 
correlates of personal and vicarious reward: a quantitative meta-analysis. 
NeuroImage 112, 244–253 (2015).
 16. Pedroni, A., Eisenegger, C., Hartmann, M. N., Fischbacher, U. & Knoch, D. 
Dopaminergic stimulation increases selfish behavior in the absence of 
punishment threat. Psychopharmacology 231, 135–141 (2014).
 17. Rosenzweig, P. et al. A review of the pharmacokinetics, tolerability and 
pharmacodynamics of amisulpride in healthy volunteers. Hum. 
Psychopharmacol. 17, 1–13 (2002).
 18. Jones, B. & Rachlin, H. Social discounting. Psychol. Sci. 17, 283–286 (2006).
 19. Strombach, T. et al. Social discounting involves modulation of neural value 
signals by temporoparietal junction. Proc. Natl Acad. Sci. USA 112, 
1619–1624 (2015).
 20. Soutschek, A., Ruff, C. C., Strombach, T., Kalenscher, T. & Tobler,  
P. N. Brain stimulation reveals crucial role of overcoming self-centeredness in 
self-control. Sci. Adv. 2, e1600992 (2016).
 21. Wise, R. A. Dopamine, learning and motivation. Nat. Rev. Neurosci. 5, 
483–494 (2004).
 22. Strombach, T., Margittai, Z., Gorczyca, B. & Kalenscher, T. Gender-specific 
effects of cognitive load on social discounting. PloS ONE 11, e0165289 
(2016).
 23. Weber, S. C. et al. Dopamine D2/3- and μ -opioid receptor antagonists reduce 
cue-induced responding and reward impulsivity in humans. Transl. Psychiatr. 
6, e850 (2016).
 24. Kayser, A. S., Allen, D. C., Navarro-Cebrian, A., Mitchell, J. M. & Fields, H. 
L. Dopamine, corticostriatal connectivity, and intertemporal choice.  
J. Neurosci. 32, 9402–9409 (2012).
 25. Wagenmakers, E. J. A practical solution to the pervasive problems of p values. 
Psychonom. Bull. Rev. 14, 779–804 (2007).
 26. Jarosz, A. & Wiley, J. What are the odds? A practical guide to computing and 
reporting Bayes factors. J. Problem Solving 7, 2 (2014).
 27. Jeffreys, H. Theory of Probability 3rd edn (Oxford Univ. Press,  
New York, NY, 1961).
 28. Pine, A., Shiner, T., Seymour, B. & Dolan, R. J. Dopamine, time, and 
impulsivity in humans. J. Neurosci. 30, 8888–8896 (2010).
 29. Pessiglione, M., Seymour, B., Flandin, G., Dolan, R. J. & Frith,  
C. D. Dopamine-dependent prediction errors underpin reward-seeking 
behaviour in humans. Nature 442, 1042–1045 (2006).
 30. Ferenczi, E. A. et al. Prefrontal cortical regulation of brainwide circuit 
dynamics and reward-related behavior. Science 351, aac9698 (2016).
 31. Bartra, O., McGuire, J. T. & Kable, J. W. The valuation system: a coordinate-
based meta-analysis of BOLD fMRI experiments examining neural correlates 
of subjective value. NeuroImage 76, 412–427 (2013).
 32. Clithero, J. A. & Rangel, A. Informatic parcellation of the network  
involved in the computation of subjective value. Soc. Cogn. Affect. Neurosci. 9, 
1289–1302 (2014).
 33. McClure, S. M., Laibson, D. I., Loewenstein, G. & Cohen, J. D. Separate 
neural systems value immediate and delayed monetary rewards. Science 306, 
503–507 (2004).
 34. Bodi, N. et al. Reward-learning and the novelty-seeking personality: a 
between- and within-subjects study of the effects of dopamine agonists on 
young Parkinson’s patients. Brain 132, 2385–2395 (2009).
 35. Joel, D. et al. Sex beyond the genitalia: the human brain mosaic. Proc. Natl 
Acad. Sci. USA 112, 15468–15473 (2015).
 36. Glezerman, M. Yes, there is a female and a male brain: morphology versus 
functionality. Proc. Natl Acad. Sci. USA 113, E1971 (2016).
 37. Dittrich, M. & Leipold, K. Gender differences in time preferences. Econ. Lett. 
122, 413–415 (2014).
 38. Kitayama, S. et al. The dopamine D4 receptor gene (DRD4) moderates 
cultural difference in independent versus interdependent social orientation. 
Psychol. Sci. 25, 1169–1177 (2014).
 39. Bergemann, N., Kopitz, J., Kress, K. R. & Frick, A. Plasma amisulpride levels 
in schizophrenia or schizoaffective disorder. Eur. Neuropsychopharmacol. 14, 
245–250 (2004).
 40. Andersen, S. L. & Teicher, M. H. Sex differences in dopamine receptors and 
their relevance to ADHD. Neurosci. Biobehav. Rev. 24, 137–141 (2000).
 41. Abbas, A. I. et al. Amisulpride is a potent 5-HT7 antagonist: relevance for 
antidepressant actions in vivo. Psychopharmacology 205, 119–128 (2009).
 42. Joutsa, J. et al. Dopaminergic function and intertemporal choice. Transl. 
Psychiatr. 5, e520 (2015).
 43. Geurts, D. E., Huys, Q. J., den Ouden, H. E. & Cools, R. Serotonin and 
aversive Pavlovian control of instrumental behavior in humans. J. Neurosci. 
33, 18932–18939 (2013).
 44. Hebart, M. N. & Glascher, J. Serotonin and dopamine differentially affect 
appetitive and aversive general Pavlovian-to-instrumental transfer. 
Psychopharmacology 232, 437–451 (2015).
 45. Gasbarri, A. & Pompili, A. Serotonergic 5-HT7 receptors and cognition.  
Rev. Neurosci. 25, 311–323 (2014).
 46. Clissold, K. A., Choi, E. & Pratt, W. E. Serotonin 1A, 1B, and 7 receptors of 
the rat medial nucleus accumbens differentially regulate feeding, water intake, 
and locomotor activity. Pharmacol. Biochem. Behav. 112, 96–103 (2013).
 47. Toubia, O., Johnson, E., Evgeniou, T. & Delquie, P. Dynamic experiments for 
estimating preferences: an adaptive method of eliciting time and risk 
parameters. Manage. Sci. 59, 613–640 (2013).
 48. Kahnt, T. & Tobler, P. N. Dopamine regulates stimulus generalization in the 
human hippocampus. eLife 5, e12678 (2016).
 49. Cools, R., Gibbs, S. E., Miyakawa, A., Jagust, W. & D’Esposito, M. Working 
memory capacity predicts dopamine synthesis capacity in the human 
striatum. J. Neurosci. 28, 1208–1212 (2008).
 50. Landau, S. M., Lal, R., O’Neil, J. P., Baker, S. & Jagust, W. J. Striatal dopamine 
and working memory. Cereb. Cortex 19, 445–454 (2009).
Acknowledgements
The authors thank L. Horvath and K. Treiber for help with data collection. This work was 
supported by grants PP00P1_128574, PP00P1_150739, 00014_165884, CRSII3_141965 
NATuRe HumAN BeHAVIOuR | VOL 1 | NOVEMBER 2017 | 819–827 | www.nature.com/nathumbehav826
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved. © 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
ArticlesNaTure HumaN BeHavIour
(PNT) and 320030_143443 (ARB; PIs: C. Ruff and T. Hare) from the Swiss National 
Science Foundation, a research credit of the University of Zurich to C.J.B. (FK-16-016) 
and a Marie Curie International Incoming Fellowship PIIF-GA-2012-327196 to A.R.B. 
All funders had no role in study design, data collection and analysis, decision to publish 
or preparation of the manuscript.
Author contributions
A.S., C.J.B., A.R.B., S.C.W., B.W., T.K. and P.N.T. designed the study. A.S., C.J.B., A.R.B., 
R.S., J.t.V. and H.H. performed the research. A.S., C.J.B. and I.I.K. analysed the data. A.S. 
and P.N.T. wrote the manuscript. C.J.B., A.R.B., R.S., S.C.W., I.I.K., J.t.V., H.H., B.W. and 
T.K. edited and approved the final version of the manuscript.
Competing interests
The authors declare no competing interests.
Additional information
Supplementary information is available for this paper at https://doi.org/10.1038/
s41562-017-0226-y.
Reprints and permissions information is available at www.nature.com/reprints.
Correspondence and requests for materials should be addressed to A.S.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in 
published maps and institutional affiliations.
NATuRe HumAN BeHAVIOuR | VOL 1 | NOVEMBER 2017 | 819–827 | www.nature.com/nathumbehav 827




Corresponding author(s): Alexander Soutschek
Initial submission Revised version Final submission
Life Sciences Reporting Summary
Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life 
science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list 
items might not apply to an individual manuscript, but all fields must be completed for clarity. 
For further information on the points included in this form, see Reporting Life Sciences Research. For further information on Nature Research 
policies, including our data availability policy, see Authors & Referees and the Editorial Policy Checklist. 
`    Experimental design
1.   Sample size
Describe how sample size was determined. We planned to test approx. 30 participants per group (females vs. males). Similar 
samples sizes per experimental group have been used by previous studies that 
investigated either amisulpride effects on decision-making (Kahnt, Weber, Haker, 
Robbins, Tobler, 2015, Journal of Neuroscience) or gender differences in social 
behaviour (Strombach, Margittai, Gorczyca, & Kalenscher, 2016, PLOS One).
2.   Data exclusions
Describe any data exclusions. As described in the manuscript, one participants was excluded due to not following 
task instructions.
3.   Replication
Describe whether the experimental findings were 
reliably reproduced.
No replication experiments were conducted for the experiments described in the 
manuscript. However, the manuscript contains all information necessary to 
conduct such replication experiments.
4.   Randomization
Describe how samples/organisms/participants were 
allocated into experimental groups.
The study followed a double-blind design, participants randomly received either 
the active substance or placebo in the first session.
5.   Blinding
Describe whether the investigators were blinded to 
group allocation during data collection and/or analysis.
The study was double-blind, so neither the experimenters nor the participants 
knew which substance they received.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
6.   Statistical parameters 
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the 
Methods section if additional space is needed). 
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same 
sample was measured repeatedly
A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one- or two-sided (note: only common tests should be described solely by name; more 
complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.




`   Software
Policy information about availability of computer code
7. Software
Describe the software used to analyze the data in this 
study. 
Matlab and SPSS
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made 
available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for 
providing algorithms and software for publication provides further information on this topic.
`   Materials and reagents
Policy information about availability of materials
8.   Materials availability
Indicate whether there are restrictions on availability of 
unique materials or if these materials are only available 
for distribution by a for-profit company.
There are no restrictions on availability.
9.   Antibodies
Describe the antibodies used and how they were validated 
for use in the system under study (i.e. assay and species).
No antibodies were used.
10. Eukaryotic cell lines
a.  State the source of each eukaryotic cell line used. Does not apply.
b.  Describe the method of cell line authentication used. Does not apply.
c.  Report whether the cell lines were tested for 
mycoplasma contamination.
Does not apply.
d.  If any of the cell lines used are listed in the database 
of commonly misidentified cell lines maintained by 
ICLAC, provide a scientific rationale for their use.
Does not apply.
`    Animals and human research participants
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
11. Description of research animals
Provide details on animals and/or animal-derived 
materials used in the study.
Does not apply.
Policy information about studies involving human research participants
12. Description of human research participants
Describe the covariate-relevant population 
characteristics of the human research participants.
The samples of female and male participants were matched with regard to age 
(mean = 23.2 years), body mass index, and working memory capacity.







Corresponding author(s): Alexander Soutschek
Initial submission Revised version Final submission
MRI Studies Reporting Summary
 Form fields will expand as needed. Please do not leave fields blank.
`    Experimental design
1.   Describe the experimental design. Exeriment 1: event-related design 
Experiment 2: mixed event-related and blocked design
2.   Specify the number of blocks, trials or experimental 
units per session and/or subject, and specify the 
length of each trial or block (if trials are blocked) 
and interval between trials.
Experiment 1: 160 trials, mean ITI = 6s 
Experiment 2: participants performed 5 runs, each with 42 trials for 
interpersonal decision task and 20 trials for intertemporal decision task; 
trial length 9.5-22.5 s (mean 11.5s)
3.   Describe how behavioral performance was 
measured.
We assessed choices (prosocial vs. selfish or larger-later vs. smaller-
sooner) in the decision tasks.
`    Acquisition
4.   Imaging
a. Specify the type(s) of imaging. fMRI
b. Specify the field strength (in Tesla). 3 Tesla
c. Provide the essential sequence imaging parameters. Experiment 1: TR=2.5s, echo time=30ms, flip angle=90 degree 
Experiment 2: TR=1.565 s, echo time=30ms, flip angle=75 degree
d. For diffusion MRI, provide full details of imaging 
parameters.
does not apply
5.   State area of acquisition. whole brain
`    Preprocessing
6.   Describe the software used for preprocessing. SPM
7.   Normalization
a. If data were normalized/standardized, describe the 
approach(es).
spatial normalization of functional to individual structural data, then 
transformation into MNI space
b. Describe the template used for normalization/
transformation.
MNI space
8.   Describe your procedure for artifact and structured 
noise removal.
in Experiment 1, three participants were removed due to excessive head 
movement (>4mm). In Experiment 2, no data were removed.
9.   Define your software and/or method and criteria 
for volume censoring, and state the extent of such 
censoring.
does not apply.







`    Statistical modeling & inference
10. Define your model type and settings. General linear model (GLM) with onset regressors for prosocial and selfish 
decisions as regressors of main interest (in Experiment 2, also regressors 
for smaller-sooner vs. larger-later reward choices). The GLM included 
further onset regressors modelling the presentation of the different choice 
options, as well as movement regressors.
11. Specify the precise effect tested. Gender-difference in striatum activity related to prosocial vs. selfish 
decisions.
12. Analysis
a. Specify whether analysis is whole brain or ROI-based. Both whole brain and ROI (striatum).
b. If ROI-based, describe how anatomical locations were 
determined.
ROI for striatum was based on previous meta-analyses.
13. State the statistic type for inference. 
(See Eklund et al. 2016.)
For the exploratory whole brain analysis, we used a cluster-inducing 
threshold of p < 0.001, k > 5.
14. Describe the type of correction and how it is 
obtained for multiple comparisons.
For the exploratory whole brain analysis, no correction for multiple 
comparisons was used.
15. Connectivity
a. For functional and/or effective connectivity, report the 
measures of dependence used and the model details.
Does not apply
b. For graph analysis, report the dependent variable and 
functional connectivity measure.
Does not apply.
16. For multivariate modeling and predictive analysis, 
specify independent variables, features extraction 
and dimension reduction, model, training and 
evaluation metrics.
Does not apply.
